These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30098419)

  • 1. Prostate cancer sheds the αvβ3 integrin in vivo through exosomes.
    Krishn SR; Singh A; Bowler N; Duffy AN; Friedman A; Fedele C; Kurtoglu S; Tripathi SK; Wang K; Hawkins A; Sayeed A; Goswami CP; Thakur ML; Iozzo RV; Peiper SC; Kelly WK; Languino LR
    Matrix Biol; 2019 Apr; 77():41-57. PubMed ID: 30098419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal αvβ6 integrin is required for monocyte M2 polarization in prostate cancer.
    Lu H; Bowler N; Harshyne LA; Craig Hooper D; Krishn SR; Kurtoglu S; Fedele C; Liu Q; Tang HY; Kossenkov AV; Kelly WK; Wang K; Kean RB; Weinreb PH; Yu L; Dutta A; Fortina P; Ertel A; Stanczak M; Forsberg F; Gabrilovich DI; Speicher DW; Altieri DC; Languino LR
    Matrix Biol; 2018 Sep; 70():20-35. PubMed ID: 29530483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome-mediated Transfer of αvβ3 Integrin from Tumorigenic to Nontumorigenic Cells Promotes a Migratory Phenotype.
    Singh A; Fedele C; Lu H; Nevalainen MT; Keen JH; Languino LR
    Mol Cancer Res; 2016 Nov; 14(11):1136-1146. PubMed ID: 27439335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.
    Padda RS; Deng FK; Brett SI; Biggs CN; Durfee PN; Brinker CJ; Williams KC; Leong HS
    Prostate; 2019 May; 79(6):592-603. PubMed ID: 30680751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the αVβ3 integrin affects prostate cancer sEV cargo and density and promotes sEV pro-tumorigenic activity in vivo through a GPI-anchored receptor, NgR2.
    Verrillo CE; Quaglia F; Shields CD; Lin S; Kossenkov AV; Tang HY; Speicher D; Naranjo NM; Testa A; Kelly WK; Liu Q; Leiby B; Musante L; Sossey-Alaoui K; Dogra N; Chen TY; Altieri DC; Languino LR
    J Extracell Vesicles; 2024 Aug; 13(8):e12482. PubMed ID: 39105261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate field cancerization and exosomes: Association between CD9, early growth response 1 and fatty acid synthase.
    Amirrad F; Pytak PA; Sadeghiani-Pelar N; Nguyen JPT; Cauble EL; Jones AC; Bisoffi M
    Int J Oncol; 2020 Apr; 56(4):957-968. PubMed ID: 32319557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of αVβ3 and αVβ6 integrins in prostate cancer progression.
    Quaglia F; Krishn SR; Wang Y; Goodrich DW; McCue P; Kossenkov AV; Mandigo AC; Knudsen KE; Weinreb PH; Corey E; Kelly WK; Languino LR
    PLoS One; 2021; 16(1):e0244985. PubMed ID: 33481853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer.
    Kawakami K; Fujita Y; Matsuda Y; Arai T; Horie K; Kameyama K; Kato T; Masunaga K; Kasuya Y; Tanaka M; Mizutani K; Deguchi T; Ito M
    BMC Cancer; 2017 May; 17(1):316. PubMed ID: 28476099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells.
    Liu T; Mendes DE; Berkman CE
    Int J Oncol; 2014 Mar; 44(3):918-22. PubMed ID: 24424840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer.
    Testa A; Quaglia F; Naranjo NM; Verrillo CE; Shields CD; Lin S; Pickles MW; Hamza DF; Von Schalscha T; Cheresh DA; Leiby B; Liu Q; Ding J; Kelly WK; Hooper DC; Corey E; Plow EF; Altieri DC; Languino LR
    Matrix Biol; 2023 Dec; 124():49-62. PubMed ID: 37956856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer.
    Martens-Uzunova ES; Kusuma GD; Crucitta S; Lim HK; Cooper C; Riches JE; Azad A; Ochiya T; Boyle GM; Southey MC; Del Re M; Lim R; Ramm GA; Jenster GW; Soekmadji C
    J Extracell Vesicles; 2021 Aug; 10(10):e12136. PubMed ID: 34434533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling.
    McCabe NP; De S; Vasanji A; Brainard J; Byzova TV
    Oncogene; 2007 Sep; 26(42):6238-43. PubMed ID: 17369840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
    Kumar D; Gupta D; Shankar S; Srivastava RK
    Oncotarget; 2015 Feb; 6(5):3280-91. PubMed ID: 25682864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.
    Khan S; Jutzy JM; Valenzuela MM; Turay D; Aspe JR; Ashok A; Mirshahidi S; Mercola D; Lilly MB; Wall NR
    PLoS One; 2012; 7(10):e46737. PubMed ID: 23091600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
    Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
    Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CD9, CD81, and CD151 EC2 domains bind to the classical RGD-binding site of integrin αvβ3.
    Yu J; Lee CY; Changou CA; Cedano-Prieto DM; Takada YK; Takada Y
    Biochem J; 2017 Feb; 474(4):589-596. PubMed ID: 27993971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The αvβ6 integrin is transferred intercellularly via exosomes.
    Fedele C; Singh A; Zerlanko BJ; Iozzo RV; Languino LR
    J Biol Chem; 2015 Feb; 290(8):4545-4551. PubMed ID: 25568317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells.
    Verma K; Gupta N; Zang T; Wangtrakluldee P; Srivastava SK; Penning TM; Trippier PC
    Mol Cancer Ther; 2018 Sep; 17(9):1833-1845. PubMed ID: 29891491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α
    Wang T; Huang J; Vue M; Alavian MR; Goel HL; Altieri DC; Languino LR; FitzGerald TJ
    Mol Cancer Res; 2019 Feb; 17(2):398-408. PubMed ID: 30266752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the tumor suppressor PTEN through exosomes: a diagnostic potential for prostate cancer.
    Gabriel K; Ingram A; Austin R; Kapoor A; Tang D; Majeed F; Qureshi T; Al-Nedawi K
    PLoS One; 2013; 8(7):e70047. PubMed ID: 23936141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.